AI-Driven Light-Spectrum Optimization for Photonic Drug Discovery

This 22nd article in the PAI-DDP series presents the AI-Spectral Photonic Optimization Module (AIS-POM), an advanced extension of the Photonically-Assisted AI Drug Design Pipeline. The framework introduces adaptive spectral control, allowing AI algorithms to dynamically adjust photon wavelengths during simulations for optimal molecular interactions. Key features include: 1. Adaptive Spectral Photonics: Dynamic wavelength modulation to maximize energy transfer and binding efficiency. 2. AI-Based Spectral Control: Neural networks analyze simulation outputs in real time, refining light parameters for best molecular response. 3. Molecular Feedback Loop: Continuous adjustment of molecular models based on photonic feedback, enabling self-optimizing drug candidate generation. Applications span oncology, virology, neurodegenerative diseases, and antimicrobial drug design, providing high-speed, precise, and intelligent drug discovery. This framework represents a major leap in computational pharmacology, transforming light into an active, intelligent parameter driving molecular design.